View Future GrowthPURE Bioscience 과거 순이익 실적과거 기준 점검 0/6PURE Bioscience 의 수입은 연평균 -8.5%의 비율로 감소해 온 반면, Household Products 산업은 연평균 1.7%의 비율로 증가했습니다. 매출은 연평균 24.5%의 비율로 감소해 왔습니다.핵심 정보-8.54%순이익 성장률-3.86%주당순이익(EPS) 성장률Household Products 산업 성장률1.51%매출 성장률-24.54%자기자본이익률n/a순이익률-89.78%최근 순이익 업데이트31 Jan 2026최근 과거 실적 업데이트업데이트 없음모든 업데이트 보기Recent updates공시 • Dec 19PURE Bioscience, Inc., Annual General Meeting, Feb 17, 2026PURE Bioscience, Inc., Annual General Meeting, Feb 17, 2026. Location: springhill suites huntington beach orange county, 7872 edinger avenue, ca 92647., huntington beach United States공시 • Nov 20PURE Bioscience, Inc. Announces Executive ChangesPURE Bioscience, Inc. announced that the Company has appointed Jeff Kitchell as President, in addition to his ongoing responsibilities as Corporate Secretary, and Dolana Blount as Vice President of Operations, in addition to her ongoing responsibilities as Vice President of Regulatory Affairs, in each case, effective as of November 17, 2025. Robert Bartlett will continue in his role as a Board Member and Chief Executive Officer, but will step down as President. The decision to separate the President and CEO roles allows Mr. Bartlett to devote his attention more exclusively to his responsibilities as CEO. Mr. Kitchell brings more than 24 years of experience with PURE, having served in multiple leadership roles, including most recently as Vice President of Operations. His deep operational expertise and long-standing dedication to the Company position him well to guide PURE’s next phase of execution and strategic development. Ms. Blount, a 27-year veteran of the Company, has held numerous leadership positions and played a significant role in the Company’s intellectual property and product development. Her expanded responsibilities reflect her strong operational capabilities and continued leadership across critical areas of the business.공시 • Jun 03PURE Bioscience, Inc. Unveils Revolutionary Membrane Treatment Solution for the Dairy and Beverage IndustryPURE Bioscience, Inc. announced an innovative application method for membrane treatment in the dairy and beverage industry using PURE®? Hard Surface. This solution addresses common membrane fouling and sanitization challenges, delivering outstanding results that enable operators to restore throughput and sanitize the membrane without damage or oxidation. Key Attributes of PURE Hard Surface for Membrane Treatment: One Treatment--Zero Compromises: Achieve superior results with just one treatment. PURE Hard Surface effectively removes fouling, restores flow, and delays the need for membrane replacement without compromising membrane integrity. Proven Performance: The solution boasts results with successful treatments demonstrating an impressive 4+ log reduction in 120 seconds. Additionally, it is NSF-listed, making it ideal for eliminating harmful bacteria in the dairy industry without causing membrane oxidation. Complete Penetration in Minutes: In practical applications, treatment has shown complete membrane penetration within 5 minutes for reverse osmosis (RO) systems, effectively scrubbing away fouling and restoring throughput. Similarly, ultrafiltration treatment (UF) systems resulted in immediate penetration and unmatched restoration of throughput while sanitizing to meet stringent quality specifications. Simplicity and Effectiveness: Membrane operators prefer PURE Hard Surface for its no-hassle approach. The ready-to-use formula requires no mixing--fill and go. Plus, with the lowest EPA toxicity rating, there is no need for personal protective equipment, making it highly safe for staff. Environmentally Safe: treatment poses no risks to wastewater systems, ensuring no impact on digesters or discharge permit compliance. Cost-Effective Solution: With just one treatment, manufacturers can sell full-priced finished goods, reduce operational costs, and significantly prolong the lifespan of their membranes, contributing to overall operational efficiency.공시 • Dec 13PURE Bioscience, Inc., Annual General Meeting, Jan 22, 2025PURE Bioscience, Inc., Annual General Meeting, Jan 22, 2025. Location: springhill suites huntington beach orange county, 7872 edinger avenue, ca 92647, huntington beach United States공시 • May 08PURE Bioscience Appoints Darin Zehr to Board of DirectorsPURE Bioscience, Inc. reported the appointment of Darin Zehr to its Board of Directors, effective as of May 1, 2024. Mr. Zehr joins as an independent director and will also serve as a member of PURE’s Audit Committee and Compensation Committee. Mr. Zehr brings extensive experience working in the food industry. Since 1990, he has held various roles in food quality and safety, sanitation, and operations management. He is the General Manager of Commercial Food Sanitation LLC (CFS). CFS, an Intralox Company, is a global food safety consulting and training organization that works across all food industry segments and has operations in North and South America, Europe, Asia, and Australia. Prior to this role, Mr. Zehr spent 22 years with Kraft Foods where he held numerous roles in operations, including Area Sanitation Manager, Business Unit Manager, and Plant Manager. He is Treasurer of the Board of Directors for Beaver Camp, a non-profit Christian Camping establishment, a former board member of the New York State Cheese Manufacturer’s Association, and former board member of the Lewis County General Hospital. Mr. Zehr received a Bachelor of Science degree in Chemistry from The State University of New York (SUNY) at Oswego. He lives in Northern New York with his wife of 30 years and has three adult children.공시 • Jan 11PURE Bioscience, Inc., Annual General Meeting, Feb 21, 2024PURE Bioscience, Inc., Annual General Meeting, Feb 21, 2024, at 10:30 Pacific Standard Time. Location: SpringHill Suites Huntington Beach Orange County - 7872 Edinger Avenue Huntington Beach California United States Agenda: To elect six directors; to ratify the appointment of Weinberg & Company, P.A. as independent registered public accounting firm for the fiscal year ending July 31, 2024; to approve, on a non-binding advisory basis, the compensation of named executive officers, during the fiscal year ended July 31, 2023; to approve the PURE Bioscience, Inc. 2024 Equity Incentive Plan; and to approve an amendment Certificate of Incorporation to increase the authorized number of shares of common stock from 150,000,000 shares to 200,000,000 shares.공시 • Feb 12PURE Bioscience, Inc. Announces Board AppointmentsPURE Bioscience, Inc. announced that at its Annual Meeting of Stockholders held on February 08, 2023, elected Robert Bartlett and Bernard Blotner as Directors.공시 • Dec 24PURE Bioscience, Inc., Annual General Meeting, Feb 08, 2023PURE Bioscience, Inc., Annual General Meeting, Feb 08, 2023, at 10:30 Pacific Standard Time. Location: 9669 Hermosa Avenue Rancho Cucamonga California United States Agenda: To elect seven directors to hold office until the next annual meeting and until their respective successors are elected and qualified; to ratify the appointment of Weinberg & Company, P.A. as independent registered public accounting firm for the fiscal year ending July 31, 2023; and to approve, on a non-binding advisory basis, the compensation of named executive officers, during the fiscal year ended July 31, 2022; and to transact such other business as may properly be brought before the meeting or any adjournment or postponement thereof.공시 • Jun 15PURE Bioscience, Inc. Hires Zhinong Yan as Executive Vice President of Science and Business DevelopmentPURE Bioscience, Inc. has hired Dr. Zhinong Yan as Executive Vice President of Science and Business Development. Dr. Yan has over 30 years of academic and industry experience in microbiology and food safety. Since joining PURE, Dr. Yan was instrumental in technical discussions with Hydrite and other PURE distributors. He also introduced PURE to global food companies and is guiding research on applications of PURE Control® at the University of Georgia and California Polytechnic State University, San Luis Obispo. Prior to joining PURE, Dr. Yan was the Executive Director of Walmart’s® Food Safety Collaboration Center in Beijing, China, and the Food Safety Director for Ecolab® in the Asia Pacific region. Dr. Yan also has served as the Senior Food Safety Scientist for Commercial Food Sanitation®, Intralox® and Mol Belting Systems®. Before working in industry, he was a research assistant professor at Michigan State University focusing on industry food safety needs, including sanitation. Dr. Yan has been actively engaged in food safety-related associations and promoting food safety globally with his strong leadership and networking. Dr. Yan received his Ph.D. from Auburn University in plant pathology.공시 • Mar 17PURE Bioscience, Inc. Announces the Successful Completion of A Federal Aviation AdministrationPURE Bioscience, Inc. announced the successful completion of a Federal Aviation Administration (FAA) evaluation of PURE Bioscience’s PURE Hard Surface sanitizer and disinfectant product for use in FAA locations. Following a vetting process which took several weeks, the FAA approved and announced that PURE Hard Surface was the only antimicrobial on the Environmental Protection Agency (EPA) List N (antimicrobials approved for use against COVID-19) authorized to be used in FAA locations such as airports, control towers, radar centers and regional control centers. Following the success of a FAA pilot testing program, the FAA is requiring its janitorial service providers for FAA locations to sanitize daily using PURE Hard Surface. To date, there are 85 FAA locations, including major airports, that are sanitized with PURE Hard Surface.공시 • Jan 28PURE Bioscience, Inc. Announces Board and Committee AppointmentsPURE Bioscience, Inc. announced the addition of three new members to the Board of Directors with the election of Kristin A. Taylor, David M. Rendall and Tom Myers. Ms. Taylor and Mr. Rendall also will serve on the audit and compensation committees of the Board of Directors. PURE also announced the appointment of Dr. Scott Harris and Dr. Martin Wiedmann to the Scientific Advisory Board. New Members of Board of Directors: Kristin A. Taylor is an accomplished technology executive with over 20 years of experience that includes VP and Director roles at leading tech companies. In May 2020, Ms. Taylor was named President and CEO of ImageWare Systems, Inc. David M. Rendall is an attorney and licensed real estate broker in the state of California. Mr. Rendall has been the broker and owner of RE/MAX of Santa Clarita, RE/MAX of Valencia, and RE/MAX Gateway since February 2014. Mr. Rendall manages approximately 175 agents and has annual sales of about $1 billion. Tom Myers has served as the Chief Operating Officer of PURE since October 2018. He previously served as Executive Vice President, Technical Support Services and in other roles after joining PURE in 2011. Mr. Myers has over 40 years of food industry experience focusing on operations management, quality control and assurance, research and development, product and process development, plant design and construction, food safety and regulatory compliance. Prior to joining PURE, Mr. Myers served as the President and Principal of Idaho Milk Products, where he built a $105 million green field dairy proteins plant and launched a worldwide business with annual revenues in excess of $200 million. New Members of Scientific Advisory Board: Dr. Scott Harris is an accomplished environmental health and safety professional with over 30 years of experience in the private sector, in federal and state regulatory agencies and more recently as an adjunct professor of Environmental Science at the University of Texas at San Antonio. He currently holds the position of President of Environmental Quality Management, a national environmental consulting, engineering and remediation service provider to the government and private sectors. Dr. Martin Wiedmann is currently the Gellert Family Professor of Food Safety at Cornell University. He has authored over 400 peer-reviewed publications, which have been cited over 25,000 times. He and his team have received multiple awards from leading institutions for advancing food safety for over two decades. He received his doctorate in Veterinary Medicine from Ludwig Maximilian University of Munich and his Ph.D. in food science from Cornell University.공시 • Dec 10PURE Bioscience, Inc., Annual General Meeting, Dec 09, 2020PURE Bioscience, Inc., Annual General Meeting, Dec 09, 2020, at 10:00 Pacific Standard Time. Agenda: To elect five directors to hold office until the next annual meeting and until their respective successors are elected and qualified; to ratify the appointment of Weinberg & Company, P.A. as its independent registered public accounting firm for the fiscal year ending July 31, 2021; to approve, on a non-binding advisory basis, the compensation of the named executive officers, during the fiscal year ended July 31, 2020; and approve an amendment and restatement of the 2017 Equity Incentive Plan to increase the number of shares reserved under the plan by 5,000,000 shares; and to transact such other business as may properly be brought before the meeting or any adjournment or postponement thereof.공시 • Nov 12Pure Bioscience and Smartwash Solutions Release Smartwash Boost Pretreatment StudyPURE Bioscience, Inc. and SmartWash Solutions®, jointly announced recent successful study results documenting that the pretreatment use of SmartWash Boost dramatically reduces the risk of foodborne illness in iceberg and romaine lettuce by increasing lethality. The pretreatment combines PURE Biosciences SDC based PURE Control® and SmartWash Solutions chemistry to “boost” the established lethality of the free chlorine wash process and increase E. coli die-off by more than 0.7 log when used with industry food-safety best practices. A recent study presented by the USDA-ARS shows that SmartWash Boost, a patent-pending process aid used to pretreat iceberg and romaine lettuce prior to washing, increases lethality and accelerates the death of E. coli during cold storage.매출 및 비용 세부 내역PURE Bioscience가 돈을 벌고 사용하는 방법. 최근 발표된 LTM 실적 기준.순이익 및 매출 추이OTCPK:PURE 매출, 비용 및 순이익 (USD Millions)날짜매출순이익일반관리비연구개발비31 Jan 262-23031 Oct 252-23031 Jul 252-23030 Apr 252-33031 Jan 252-34031 Oct 242-34031 Jul 242-34030 Apr 242-44031 Jan 242-44031 Oct 232-44031 Jul 232-44030 Apr 232-44031 Jan 232-44031 Oct 222-44031 Jul 222-34030 Apr 222-34031 Jan 222-34031 Oct 213-34031 Jul 214-24030 Apr 21704031 Jan 21914031 Oct 20813031 Jul 20704030 Apr 204-24031 Jan 202-44031 Oct 192-55031 Jul 192-76030 Apr 192-77031 Jan 192-77031 Oct 182-88031 Jul 182-77030 Apr 182-88031 Jan 182-87131 Oct 172-77131 Jul 172-66130 Apr 172-56131 Jan 172-36131 Oct 162-137131 Jul 161-147130 Apr 161-167131 Jan 161-188131 Oct 151-97131 Jul 151-871양질의 수익: PURE 은(는) 현재 수익성이 없습니다.이익 마진 증가: PURE는 현재 수익성이 없습니다.잉여현금흐름 대비 순이익 분석과거 순이익 성장 분석수익추이: PURE은 수익성이 없으며 지난 5년 동안 손실이 연평균 8.5% 증가했습니다.성장 가속화: 현재 수익성이 없어 지난 1년간 PURE의 수익 성장률을 5년 평균과 비교할 수 없습니다.수익 대 산업: PURE은 수익성이 없어 지난 해 수익 성장률을 Household Products 업계(11.7%)와 비교하기 어렵습니다.자기자본이익률높은 ROE: PURE의 부채가 자산을 초과하여 자본 수익률을 계산하기 어렵습니다.총자산이익률투하자본수익률우수한 과거 실적 기업을 찾아보세요7D1Y7D1Y7D1YHousehold 산업에서 과거 실적이 우수한 기업.View Financial Health기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/05/20 08:34종가2026/05/20 00:00수익2026/01/31연간 수익2025/07/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스PURE Bioscience, Inc.는 1명의 분석가가 다루고 있습니다. 이 중 0명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.분석가기관Keith MarkeyGriffin Securities
공시 • Dec 19PURE Bioscience, Inc., Annual General Meeting, Feb 17, 2026PURE Bioscience, Inc., Annual General Meeting, Feb 17, 2026. Location: springhill suites huntington beach orange county, 7872 edinger avenue, ca 92647., huntington beach United States
공시 • Nov 20PURE Bioscience, Inc. Announces Executive ChangesPURE Bioscience, Inc. announced that the Company has appointed Jeff Kitchell as President, in addition to his ongoing responsibilities as Corporate Secretary, and Dolana Blount as Vice President of Operations, in addition to her ongoing responsibilities as Vice President of Regulatory Affairs, in each case, effective as of November 17, 2025. Robert Bartlett will continue in his role as a Board Member and Chief Executive Officer, but will step down as President. The decision to separate the President and CEO roles allows Mr. Bartlett to devote his attention more exclusively to his responsibilities as CEO. Mr. Kitchell brings more than 24 years of experience with PURE, having served in multiple leadership roles, including most recently as Vice President of Operations. His deep operational expertise and long-standing dedication to the Company position him well to guide PURE’s next phase of execution and strategic development. Ms. Blount, a 27-year veteran of the Company, has held numerous leadership positions and played a significant role in the Company’s intellectual property and product development. Her expanded responsibilities reflect her strong operational capabilities and continued leadership across critical areas of the business.
공시 • Jun 03PURE Bioscience, Inc. Unveils Revolutionary Membrane Treatment Solution for the Dairy and Beverage IndustryPURE Bioscience, Inc. announced an innovative application method for membrane treatment in the dairy and beverage industry using PURE®? Hard Surface. This solution addresses common membrane fouling and sanitization challenges, delivering outstanding results that enable operators to restore throughput and sanitize the membrane without damage or oxidation. Key Attributes of PURE Hard Surface for Membrane Treatment: One Treatment--Zero Compromises: Achieve superior results with just one treatment. PURE Hard Surface effectively removes fouling, restores flow, and delays the need for membrane replacement without compromising membrane integrity. Proven Performance: The solution boasts results with successful treatments demonstrating an impressive 4+ log reduction in 120 seconds. Additionally, it is NSF-listed, making it ideal for eliminating harmful bacteria in the dairy industry without causing membrane oxidation. Complete Penetration in Minutes: In practical applications, treatment has shown complete membrane penetration within 5 minutes for reverse osmosis (RO) systems, effectively scrubbing away fouling and restoring throughput. Similarly, ultrafiltration treatment (UF) systems resulted in immediate penetration and unmatched restoration of throughput while sanitizing to meet stringent quality specifications. Simplicity and Effectiveness: Membrane operators prefer PURE Hard Surface for its no-hassle approach. The ready-to-use formula requires no mixing--fill and go. Plus, with the lowest EPA toxicity rating, there is no need for personal protective equipment, making it highly safe for staff. Environmentally Safe: treatment poses no risks to wastewater systems, ensuring no impact on digesters or discharge permit compliance. Cost-Effective Solution: With just one treatment, manufacturers can sell full-priced finished goods, reduce operational costs, and significantly prolong the lifespan of their membranes, contributing to overall operational efficiency.
공시 • Dec 13PURE Bioscience, Inc., Annual General Meeting, Jan 22, 2025PURE Bioscience, Inc., Annual General Meeting, Jan 22, 2025. Location: springhill suites huntington beach orange county, 7872 edinger avenue, ca 92647, huntington beach United States
공시 • May 08PURE Bioscience Appoints Darin Zehr to Board of DirectorsPURE Bioscience, Inc. reported the appointment of Darin Zehr to its Board of Directors, effective as of May 1, 2024. Mr. Zehr joins as an independent director and will also serve as a member of PURE’s Audit Committee and Compensation Committee. Mr. Zehr brings extensive experience working in the food industry. Since 1990, he has held various roles in food quality and safety, sanitation, and operations management. He is the General Manager of Commercial Food Sanitation LLC (CFS). CFS, an Intralox Company, is a global food safety consulting and training organization that works across all food industry segments and has operations in North and South America, Europe, Asia, and Australia. Prior to this role, Mr. Zehr spent 22 years with Kraft Foods where he held numerous roles in operations, including Area Sanitation Manager, Business Unit Manager, and Plant Manager. He is Treasurer of the Board of Directors for Beaver Camp, a non-profit Christian Camping establishment, a former board member of the New York State Cheese Manufacturer’s Association, and former board member of the Lewis County General Hospital. Mr. Zehr received a Bachelor of Science degree in Chemistry from The State University of New York (SUNY) at Oswego. He lives in Northern New York with his wife of 30 years and has three adult children.
공시 • Jan 11PURE Bioscience, Inc., Annual General Meeting, Feb 21, 2024PURE Bioscience, Inc., Annual General Meeting, Feb 21, 2024, at 10:30 Pacific Standard Time. Location: SpringHill Suites Huntington Beach Orange County - 7872 Edinger Avenue Huntington Beach California United States Agenda: To elect six directors; to ratify the appointment of Weinberg & Company, P.A. as independent registered public accounting firm for the fiscal year ending July 31, 2024; to approve, on a non-binding advisory basis, the compensation of named executive officers, during the fiscal year ended July 31, 2023; to approve the PURE Bioscience, Inc. 2024 Equity Incentive Plan; and to approve an amendment Certificate of Incorporation to increase the authorized number of shares of common stock from 150,000,000 shares to 200,000,000 shares.
공시 • Feb 12PURE Bioscience, Inc. Announces Board AppointmentsPURE Bioscience, Inc. announced that at its Annual Meeting of Stockholders held on February 08, 2023, elected Robert Bartlett and Bernard Blotner as Directors.
공시 • Dec 24PURE Bioscience, Inc., Annual General Meeting, Feb 08, 2023PURE Bioscience, Inc., Annual General Meeting, Feb 08, 2023, at 10:30 Pacific Standard Time. Location: 9669 Hermosa Avenue Rancho Cucamonga California United States Agenda: To elect seven directors to hold office until the next annual meeting and until their respective successors are elected and qualified; to ratify the appointment of Weinberg & Company, P.A. as independent registered public accounting firm for the fiscal year ending July 31, 2023; and to approve, on a non-binding advisory basis, the compensation of named executive officers, during the fiscal year ended July 31, 2022; and to transact such other business as may properly be brought before the meeting or any adjournment or postponement thereof.
공시 • Jun 15PURE Bioscience, Inc. Hires Zhinong Yan as Executive Vice President of Science and Business DevelopmentPURE Bioscience, Inc. has hired Dr. Zhinong Yan as Executive Vice President of Science and Business Development. Dr. Yan has over 30 years of academic and industry experience in microbiology and food safety. Since joining PURE, Dr. Yan was instrumental in technical discussions with Hydrite and other PURE distributors. He also introduced PURE to global food companies and is guiding research on applications of PURE Control® at the University of Georgia and California Polytechnic State University, San Luis Obispo. Prior to joining PURE, Dr. Yan was the Executive Director of Walmart’s® Food Safety Collaboration Center in Beijing, China, and the Food Safety Director for Ecolab® in the Asia Pacific region. Dr. Yan also has served as the Senior Food Safety Scientist for Commercial Food Sanitation®, Intralox® and Mol Belting Systems®. Before working in industry, he was a research assistant professor at Michigan State University focusing on industry food safety needs, including sanitation. Dr. Yan has been actively engaged in food safety-related associations and promoting food safety globally with his strong leadership and networking. Dr. Yan received his Ph.D. from Auburn University in plant pathology.
공시 • Mar 17PURE Bioscience, Inc. Announces the Successful Completion of A Federal Aviation AdministrationPURE Bioscience, Inc. announced the successful completion of a Federal Aviation Administration (FAA) evaluation of PURE Bioscience’s PURE Hard Surface sanitizer and disinfectant product for use in FAA locations. Following a vetting process which took several weeks, the FAA approved and announced that PURE Hard Surface was the only antimicrobial on the Environmental Protection Agency (EPA) List N (antimicrobials approved for use against COVID-19) authorized to be used in FAA locations such as airports, control towers, radar centers and regional control centers. Following the success of a FAA pilot testing program, the FAA is requiring its janitorial service providers for FAA locations to sanitize daily using PURE Hard Surface. To date, there are 85 FAA locations, including major airports, that are sanitized with PURE Hard Surface.
공시 • Jan 28PURE Bioscience, Inc. Announces Board and Committee AppointmentsPURE Bioscience, Inc. announced the addition of three new members to the Board of Directors with the election of Kristin A. Taylor, David M. Rendall and Tom Myers. Ms. Taylor and Mr. Rendall also will serve on the audit and compensation committees of the Board of Directors. PURE also announced the appointment of Dr. Scott Harris and Dr. Martin Wiedmann to the Scientific Advisory Board. New Members of Board of Directors: Kristin A. Taylor is an accomplished technology executive with over 20 years of experience that includes VP and Director roles at leading tech companies. In May 2020, Ms. Taylor was named President and CEO of ImageWare Systems, Inc. David M. Rendall is an attorney and licensed real estate broker in the state of California. Mr. Rendall has been the broker and owner of RE/MAX of Santa Clarita, RE/MAX of Valencia, and RE/MAX Gateway since February 2014. Mr. Rendall manages approximately 175 agents and has annual sales of about $1 billion. Tom Myers has served as the Chief Operating Officer of PURE since October 2018. He previously served as Executive Vice President, Technical Support Services and in other roles after joining PURE in 2011. Mr. Myers has over 40 years of food industry experience focusing on operations management, quality control and assurance, research and development, product and process development, plant design and construction, food safety and regulatory compliance. Prior to joining PURE, Mr. Myers served as the President and Principal of Idaho Milk Products, where he built a $105 million green field dairy proteins plant and launched a worldwide business with annual revenues in excess of $200 million. New Members of Scientific Advisory Board: Dr. Scott Harris is an accomplished environmental health and safety professional with over 30 years of experience in the private sector, in federal and state regulatory agencies and more recently as an adjunct professor of Environmental Science at the University of Texas at San Antonio. He currently holds the position of President of Environmental Quality Management, a national environmental consulting, engineering and remediation service provider to the government and private sectors. Dr. Martin Wiedmann is currently the Gellert Family Professor of Food Safety at Cornell University. He has authored over 400 peer-reviewed publications, which have been cited over 25,000 times. He and his team have received multiple awards from leading institutions for advancing food safety for over two decades. He received his doctorate in Veterinary Medicine from Ludwig Maximilian University of Munich and his Ph.D. in food science from Cornell University.
공시 • Dec 10PURE Bioscience, Inc., Annual General Meeting, Dec 09, 2020PURE Bioscience, Inc., Annual General Meeting, Dec 09, 2020, at 10:00 Pacific Standard Time. Agenda: To elect five directors to hold office until the next annual meeting and until their respective successors are elected and qualified; to ratify the appointment of Weinberg & Company, P.A. as its independent registered public accounting firm for the fiscal year ending July 31, 2021; to approve, on a non-binding advisory basis, the compensation of the named executive officers, during the fiscal year ended July 31, 2020; and approve an amendment and restatement of the 2017 Equity Incentive Plan to increase the number of shares reserved under the plan by 5,000,000 shares; and to transact such other business as may properly be brought before the meeting or any adjournment or postponement thereof.
공시 • Nov 12Pure Bioscience and Smartwash Solutions Release Smartwash Boost Pretreatment StudyPURE Bioscience, Inc. and SmartWash Solutions®, jointly announced recent successful study results documenting that the pretreatment use of SmartWash Boost dramatically reduces the risk of foodborne illness in iceberg and romaine lettuce by increasing lethality. The pretreatment combines PURE Biosciences SDC based PURE Control® and SmartWash Solutions chemistry to “boost” the established lethality of the free chlorine wash process and increase E. coli die-off by more than 0.7 log when used with industry food-safety best practices. A recent study presented by the USDA-ARS shows that SmartWash Boost, a patent-pending process aid used to pretreat iceberg and romaine lettuce prior to washing, increases lethality and accelerates the death of E. coli during cold storage.